|
RAS Therapeutics is an early-stage biotechnology company developing targeted therapies for a number of cancers, including cancer of the pancreas. As one of LSGPA's portfolio companies, KGGD was enlisted to provide RAS with a flexible, memorable logo to help build their interest in their organization. |
|
|